Description
This product utilizes Synthetic CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target FcRL5 (clone F2E5L). We employs the HBV (SP6-RFP-β-catenin-EcoRI) vector components and the SynExpress system of the Exons Knock-in/Adaptive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
FcRL5
Clone
F2E5L
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
RFP
Promoter
SP6
Effector Gene
β-catenin
Insertion Sites
EcoRI
Gene Modification
Knock-in
Modification Domain
Exons
Carrier Type
HBV
Transformation Accuracy
0.91
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.